Randomisation & Sample Size – Clinical BA Study [Power / Sample Size]

posted by ElMaestro  – Denmark, 2011-02-01 15:24 (5625 d 16:43 ago) – Posting: # 6528
Views: 8,253

Hi again,

❝ We are hoping to show that the nutritional supplement increases the

❝ absorption and thus bioavailability of the drug.

❝ (...)

❝ We are also interested in examining if the different doses of the

❝ supplement affect the bioavailability of the drug to a different extent


If you have 'enough' subjects in your pivotal trial you may end up with a significant value for the ingredient addition.
However, in order to dimension such a thing you will need to have an idea about the effect size the dietary supplement. In the absence of a model for it I guess you need to either conduct a pilot trial to get an idea about the effect size in your pivotal trial or press the 'I feel lucky'-button.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
377 visitors (0 registered, 377 guests [including 19 identified bots]).
Forum time: 09:07 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5